Speaker: Dr. Jacob Kohlenberg
 
Title of the talk: Type 1 Diabetes in 2026: What Every Clinician Should Know
 
Learning Objectives:
 
1.Describe the stages of T1D and how T1D can be diagnosed before and after clinical onset
 
2.Identify who should be referred for T1D autoantibody screening, explain the role of TrialNet, and recognize teplizumab as an intervention for Stage 2 T1D
 
3.Recognize the limitations of HbA1c and interpret key CGM metrics
 
4.Recognize the emerging role of adjunct therapies (GLP-1 receptor agonists, SGLT2i) in T1D
 
5.Describe how EHR-integrated population health dashboards can shift T1D care from reactive to proactive
 
6.Recognize how social determinants of health contribute to disparities in T1D outcomes, including DKA risk
Session date: 
03/19/2026 - 12:00pm to 1:00pm EDT
Add to calendar: 
  • 1.00 ABIM MOC 2
  • 1.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Please login or register to take this course.